Search

Author/Creator Monitillo, L.

1. Ficoll‐hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis. (4th December 2017)

Authors:
Genuardi, E.; Barbero, D.; Dogliotti, I.; Mantoan, B.; Drandi, D.; Gambella, M.; Zaccaria, G. M.; Monitillo, L.; Della Starza, I.; Cavalli, M.; De Novi, L. A.; Ciabatti, E.; Grassi, S.; Gazzola, A.; Mannu, C.; Del Giudice, I.; Galimberti, S.; Agostinelli, C.; Piccaluga, P. P.; Ladetto, M.
Journal:
International journal of laboratory hematology
Issue:
Volume 40:Number 2(2018:Apr.)
Page Start:
201
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. KMT2D AND TP53 MUTATIONS PREDICT POOR PFS AND OS IN MANTLE CELL LYMPHOMA RECEIVING HIGH‐DOSE THERAPY AND ASCT: THE FONDAZIONE ITALIANA LINFOMI (FIL) MCL0208 PHASE III TRIAL. (June 2017)

Authors:
Ferrero, S.; Rossi, D.; Bruscaggin, A.; Evangelista, A.; Di Rocco, A.; Spina, V.; Stefoni, V.; Ghione, P.; Barbero, D.; Monitillo, L.; Gomes Da Silva, M.; Santoro, A.; Molinari, A.; Ferreri, A.; Piccin, A.; Cortelazzo, S.; Ladetto, M.; Gaidano, G.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
94
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. NOVEL MOLECULAR MARKERS FOR MINIMAL RESIDUAL DISEASE (MRD) MONITORING IN MANTLE CELL AND FOLLICULAR LYMPHOMA: THE TARGETED LOCUS AMPLIFICATION (TLA) NGS STRATEGY. (June 2017)

Authors:
Ferrero, S.; Genuardi, E.; Klous, P.; Drandi, D.; Mantoan, B.; Monitillo, L.; Barbero, D.; Yilmaz, M.; Cattellino, F.; Vasta, M.; Cavallo, F.; Cortelazzo, S.; Vitolo, U.; Luminari, S.; Federico, M.; Boccadoro, M.; Splinter, E.; Ladetto, M.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
151
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗